Psychotropic drugs in pregnancy: A case-control study

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 29, Issue 2, 2005, Pages 333-338

  Yaris, Fusun ^a   Ulku, Cunay ^a   Kesim, Murat ^a   Kadioglu, Mine ^a   Unsal, Mesut ^a   Dikici, Mustafa Fevzi ^b   Kalyoncu, Nuri Ihsan ^a   Yaris, Ersin ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^b ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Antidepressant; Antipsychotic; Anxiolytic; Pregnancy; Spontaneous abortion; Teratogenicity

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; ANXIOLYTIC AGENT; BENZODIAZEPINE; CHLORDIAZEPOXIDE; CLOMIPRAMINE; CLONAZEPAM; CLORAZEPATE; DIAZEPAM; FLUOXETINE; FLUVOXAMINE; HALOPERIDOL; HYDROXYZINE; MAPROTILINE; MEDAZEPAM; MIANSERIN; MIRTAZAPINE; MOCLOBEMIDE; NEFAZODONE; OPIPRAMOL; PSYCHOTROPIC AGENT; QUETIAPINE; SERTRALINE; SULPIRIDE; THIORIDAZINE; TIANEPTINE; TRIFLUOPERAZINE; UNINDEXED DRUG; VENLAFAXINE; ZUCLOPENTHIXOL;

ADOLESCENT; ADULT; ANXIETY DISORDER; ARTICLE; CONGENITAL MALFORMATION; CONTROLLED STUDY; DEPRESSION; FEMALE; FETUS DEATH; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY; PREMATURITY; PSYCHOSIS; SPONTANEOUS ABORTION;

EID: 13444270484     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2004.11.020     Document Type: Article

References (32)

1. American Psychiatric Association, 1994. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), Fourth ed. First published in the United States by American Psychiatric Association, Washington DC.
2. J. Arnon, S. Shechtman, and A. Ornoy The use of psychiatric drugs in pregnancy and lactation Isr. J. Psychiatry Relat. Sci. 37 3 2000 205 222
3. E. Beghi, and J.F. Annegers Collaborative group for the pregnancy registries in epilepsy: pregnancy registries in epilepsy Epilepsia 42 11 2001 1422 1425
4. Briggs, G.G., Freeman, R.K., Yaffe, S.J., 2002a, Drugs in pregnancy and lactation (for psychotropic drugs). Haloperidol, mesoridazine, thioridazine, trifluoperazine, zuclopenthixol. Sixth ed. Lippincott Williams and Wilkins Publishing, Philadelphia, pp: 642-644 h, 872 m, 1352 t, 1388 t, 1526 z.
5. Briggs, G.G., Freeman, R.K., Yaffe, S.J., 2002b. Drugs in pregnancy and lactation. Amitriptyline, alprazolam, clomipramine, diazepam, lithium, maprotiline, simethicone. Sixth ed. Lippincott Williams and Wilkins Publishing, Philadelphia, pp: 40-43 a, 59-62 a, 292-295 c, 390-396 d, 800-805 l, 829-830 m, 1258 s.
6. C.N. Broussard, and J.E. Richter Treating gastro-oesophageal reflux disease during pregnancy and lactation: what are the safest therapy options? Drug Safety 19 4 1998 325 337
7. C.S. Brown Depression and anxiety disorders Obstet. Gynecol. Clin. North Am. 28 2 2001 241 268 (Jun.)
8. F. Centorrino, J.L. Goren, J. Hennen, P. Salvatore, J.P. Kelleher, and R.J. Baldessarini Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits Am. J. Psychiatry 161 4 2004 700 706
9. A. Einarson, B. Fatoye, and M. Sarkar Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study Am. J. Psychiatry 158 10 2001 1728 1730
10. A. Einarson, L. Bonari, S. Voyer-Lavigne, A. Addis, D. Matsui, Y. Johnson, and G. Koren A multicentre prospective controlled study to determine the safety of trazodone and nefazodone use during pregnancy Can. J. Psychiatry 48 2 2003 106 110
11. P.M. Haddad Antidepressant discontinuation syndromes Drug Safety 24 3 2001 183 197
12. H.V. Hansen, and H.S. Andersen Psychosis and pregnancy: five cases of severely ill women Nord. J. Psychiatry 55 6 2001 433 437
13. http://meds.ktu.edu.tr/~eyaris/index.html July 13, 2004
14. I. Iancu, N. Horesh, E. Lepkifker, and Y. Drory An epidemiological study of depressive symptomatology among Israeli adults: prevalence of depressive symptoms and demographic risk factors Isr. J. Psychiatry Relat. Sci. 40 2 2003 82 89
15. B. Kallen, and I. Mottet Delivery outcome after the use of meclozine in early pregnancy Eur. J. Epidemiol. 18 7 2003 665 669
16. M. Kesim, F. Yaris, M. Kadioglu, E. Yaris, N.I. Kalyoncu, and C. Ulku Mirtazapine use in two pregnant women: is it safe? Teratol 66 5 2002 204
17. P.R. McElhatton The effects of benzodiazepine use during pregnancy and lactation Reprod. Toxicol. 8 6 1994 461 475
18. P.R. McElhatton, H.M. Garbis, and E. Elefant The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. A collaborative study of the European Network of Teratology Information Services (ENTIS) Reprod. Toxicol. 10 4 1996 285 924
19. S. Nikfar, M. Abdollahi, M.E. Moretti, L.A. Magee, and G. Koren Use of proton pump inhibitors during pregnancy and rates of major malformations: a meta-analysis Dig. Dis. Sci. 47 7 2002 1526 1529
20. H. Nordeng, and O. Spigset Use of antipsychotics during pregnancy and lactation Tidsskr. Nor. Laegeforen. 14; 123 15 2003 2033 2035
21. A. Ornoy, J. Arnon, S. Shechtman, L. Moerman, and I. Lukashova Is benzodiazepine use during pregnancy really teratogenic? Reprod. Toxicol. 12 5 1998 511 515
22. H. Parepally, S. Chakravorty, J. Levine, J.S. Brar, A.M. Patel, J.W. Baird, L. Chalasani, J.A. Delaney, R. Atzert, and K.N. Chengappa The use of concomitant medications in psychiatric inpatients treated with either olanzapine or other antipsychotic agents: a naturalistic study at a state psychiatric hospital Prog. Neuro-Psychopharmacol. Biol. Psychiatry 26 3 2002 437 440
23. S.W. Patton, S. Misri, M.R. Corral, K.F. Perry, and A.J. Kuan Antipsychotic medication during pregnancy and lactation in women with schizophrenia: evaluating the risk Can. J. Psychiatry 47 10 2002 959 965
24. T. Ratnayake, and S.E. Libretto No complications with risperidone treatment before and throughout pregnancy and during the nursing period J. Clin. Psychiatry 63 1 2002 76 77
25. A. Rohde, J. Dembinski, and C. Dorn Mirtazapine (Remergil) for treatment resistant hyperemesis gravidarum: rescue of a twin pregnancy Arch. Gynecol. Obstet. 268 3 2003 219 221
26. J.K. Rybakowski Moclobemide in pregnancy Pharmacopsychiatry 34 2 2001 82 83
27. T.H. Shepard, R.L. Brent, J.M. Friedman, K.L. Jones, R.K. Miller, C.A. Moore, and J.E. Polifka Update on new developments in the study of human teratogens Teratology 65 2002 153 161
28. T. Tenyi, M. Trixler, and Z. Keresztes Quetiapine and pregnancy Am. J. Psychiatry 159 4 2002 674
29. M. Vaswani, F.K. Linda, and S. Ramesh Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review Prog. Neuro-Psychopharmacol. Biol. Psychiatry 27 1 2003 85 102
30. R.K. Ward, and M.A. Zamorski Benefits and risks of psychiatric medications during pregnancy Am. Fam. Physician 15; 66 4 2002 629 636
31. F. Yaris, E. Yaris, M. Kadioglu, C. Ulku, M. Kesim, and N.I. Kalyoncu Use of polypharmacotherapy in pregnancy: a prospective outcome in a case Prog. Neuro-Psychopharmacol. Biol. Psychiatry 28 2004 603 605
32. F. Yaris, M. Kadioglu, M. Kesim, C. Ulku, E. Yaris, N.I. Kalyoncu, and M. Unsal Newer antidepressants in pregnancy: prospective outcome of a case series Reprod. Toxicol. 2004 (in press)